Literature DB >> 7883119

Regulation of glycogen synthase by glucose, glucosamine, and glutamine:fructose-6-phosphate amidotransferase.

E D Crook1, J Zhou, M Daniels, J L Neidigh, D A McClain.   

Abstract

The hexosamine biosynthesis pathway has been hypothesized to mediate some of the regulatory as well as the deleterious effects of glucose. We have stably overexpressed the cDNA for human glutamine:fructose-6-phosphate amidotransferase (GFA), the rate-limiting enzyme in the hexosamine biosynthesis pathway, in rat-1 fibroblasts. Two cell lines expressing the human RNA were selected by Northern analysis, and they exhibited 51-95% increases in GFA activity. Insulin-stimulated glycogen synthase (GS) activity and net glycogen synthesis were assayed, and GFA cells revealed decreased insulin sensitivity for both GS and net glycogen synthesis. The ED50 for insulin stimulation of GS was 2.45 +/- 0.4 nmol/l insulin in controls and 5.29 +/- 1.01 nmol/l in GFA cells (P < 0.005). For insulin-stimulated glycogen synthesis, the ED50 was 3.43 +/- 0.88 nmol/l in controls and 5.54 +/- 0.98 nmol/l in GFA cells (P < 0.005). There were no significant differences in maximally insulin-stimulated or total GS activities, insulin binding or receptor number, or glucose uptake between GFA and control cells. We also examined the effects of glucose on GS activity. GFA cells had a twofold increase in GS activity at low glucose (0.5 mmol/l) when compared with controls (P < 0.025). Both GFA and control cells had an approximately 75-80% decrease in GS activity as glucose concentration was increased from 0.5 to 20 mmol/l. This change in GS activity was not observed until after 12 h in culture. GFA cells were more sensitive to the effects of glucose.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7883119     DOI: 10.2337/diab.44.3.314

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  7 in total

1.  Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance.

Authors:  L F Hebert; M C Daniels; J Zhou; E D Crook; R L Turner; S T Simmons; J L Neidigh; J S Zhu; A D Baron; D A McClain
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

2.  A Genetic Model to Study Increased Hexosamine Biosynthetic Flux.

Authors:  Sarah E Hugo; Amnon Schlegel
Journal:  Endocrinology       Date:  2017-08-01       Impact factor: 4.736

3.  Influence of glucosamine on glomerular mesangial cell turnover: implications for hyperglycemia and hexosamine pathway flux.

Authors:  Leighton R James; Catherine Le; James W Scholey
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-11-10       Impact factor: 4.310

4.  Dapagliflozin Enhances Fat Oxidation and Ketone Production in Patients With Type 2 Diabetes.

Authors:  Giuseppe Daniele; Juan Xiong; Carolina Solis-Herrera; Aurora Merovci; Roy Eldor; Devjit Tripathy; Ralph A DeFronzo; Luke Norton; Muhammad Abdul-Ghani
Journal:  Diabetes Care       Date:  2016-08-25       Impact factor: 19.112

Review 5.  Nutrient and hormonal regulation of pyruvate kinase gene expression.

Authors:  K Yamada; T Noguchi
Journal:  Biochem J       Date:  1999-01-01       Impact factor: 3.857

6.  Glutamine:fructose-6-phosphate amidotransferase activity in cultured human skeletal muscle cells: relationship to glucose disposal rate in control and non-insulin-dependent diabetes mellitus subjects and regulation by glucose and insulin.

Authors:  M C Daniels; T P Ciaraldi; S Nikoulina; R R Henry; D A McClain
Journal:  J Clin Invest       Date:  1996-03-01       Impact factor: 14.808

7.  Proposed regulation of gene expression by glucose in rodent heart.

Authors:  Martin E Young; Jie Yan; Peter Razeghi; Robert C Cooksey; Patrick H Guthrie; Stanislaw M Stepkowski; Donald A McClain; Rong Tian; Heinrich Taegtmeyer
Journal:  Gene Regul Syst Bio       Date:  2007-11-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.